EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY-NC-ND 4.0

Addressing Multiplicity in Retinal Sensitivity Analysis: An Alternative Approach to Assessing Gene Therapy Efficacy in Inherited Retinal Diseases

Antonio Yaghy, David G Birch, Yunchan Hwang, Edmund Luo, JungAh Jung, Darin Curtiss, Nadia K Waheed

Translational Vision Science & Technology · 2025

DOI: 10.1167/tvst.14.3.25 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Antonio Yaghy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beacon Therapeutics, Alachua, FL, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Retinitis Pigmentosa, Retina, Retinal Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study was to propose an alternative statistical approach that addresses the issue of multiplicity in microperimetry data analysis, offering a more balanced and sensitive measure of the efficacy of gene therapy in inherited retinal diseases (IRDs).

Methods

We analyzed microperimetry data from a phase II trial of AGTC-501 in patients with X-linked retinitis pigmentosa (XLRP). The Macular Integrity Assessment (MAIA; CenterVue, Padova, Italy) device was used to evaluate test-retest repeatability. A binomial model was used to calculate the probability of ≥7 decibel (dB) improvements due to chance alone across a 68-locus grid. We proposed an alternative approach to detect changes using a threshold of ≥7 loci with ≥7 dB mean improvement.

Results

Test-retest repeatability analysis showed a probability of < 5% for observing pointwise improvements ≥7 dB between 2 baseline visits. Applying the binomial distribution model, we found that the probability of observing improvements ≥7 dB in at least 7 unspecified loci purely by chance was 5.3%.

Conclusions

The proposed approach provides a balanced way to address multiplicity while maintaining reasonable statistical significance. Using ≥7 unspecified loci as the criterion for assessing sensitivity changes, offers a comprehensive assessment that can detect genuine treatment effects without being overly conservative. Translational Relevance: This alternative statistical method has the potential to improve the evaluation of retinal sensitivity changes in gene therapy trials for IRDs, providing a more accurate measure of therapeutic efficacy and enhancing clinical decision making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyRetinitis PigmentosaRetinaRetinal DiseasesHumansVisual Field TestsMaleVisual FieldsReproducibility of ResultsAdultFemaleTreatment Outcome

Autor:innen und Institutionen

  • Beacon Therapeutics, Alachua, FL, USA.
  • Retina Foundation of the Southwest, Dallas, TX, USA.
  • Department of Electrical Engineering and Computer Science, Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA.

Zitieren

APA

Yaghy, A., Birch, D. G., Hwang, Y., Luo, E., Jung, J., Curtiss, D., & Waheed, N. K. (2025). Addressing Multiplicity in Retinal Sensitivity Analysis: An Alternative Approach to Assessing Gene Therapy Efficacy in Inherited Retinal Diseases. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.3.25

Vancouver

Yaghy A, Birch DG, Hwang Y, Luo E, Jung J, Curtiss D, et al. Addressing Multiplicity in Retinal Sensitivity Analysis: An Alternative Approach to Assessing Gene Therapy Efficacy in Inherited Retinal Diseases. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.3.25

BibTeX
@article{Yaghy2025,
  author = {Yaghy, Antonio and Birch, David G and Hwang, Yunchan and Luo, Edmund and Jung, JungAh and Curtiss, Darin and Waheed, Nadia K},
  title = {Addressing Multiplicity in Retinal Sensitivity Analysis: An Alternative Approach to Assessing Gene Therapy Efficacy in Inherited Retinal Diseases},
  journal = {Translational Vision Science & Technology},
  year = {2025},
  doi = {10.1167/tvst.14.3.25}
}
Kostenlos starten →